MIM
ONC

MetLife Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

MetLife Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,900
Closed -$831K – 2321
2020
Q3 		$831K Hold
2,900
– – 0.01% 1120
2020
Q2 		$546K Buy
2,900
+500
+21% +$81.4K 0.01% 1330
2020
Q1 		$295K Hold
2,400
– – ﹤0.01% 1485
2019
Q4 		$398K Hold
2,400
– – ﹤0.01% 1584
2019
Q3 		$294K Hold
2,400
– – ﹤0.01% 1721
2019
Q2 		$297K Hold
2,400
– – ﹤0.01% 1792
2019
Q1 		$317K Hold
2,400
– – ﹤0.01% 1724
2018
Q4 		$337K Buy
+2,400
New +$318K ﹤0.01% 1605

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

MetLife Investment Management's ONC Position: Q4 2020 in Review

MetLife Investment Management sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 2,900 shares — an estimated $831K sold.

MetLife Investment Management first reported a position in ONC in Q4 2018 and held it in 8 quarters. The position peaked at $831K in Q3 2020. 248 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

  • MetLife Investment Management reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
  • MetLife Investment Management sold 2,900 BeOne Medicines Ltd shares in Q4 2020, an estimated $831K.
  • MetLife Investment Management first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 8 quarters.
  • MetLife Investment Management's BeOne Medicines Ltd position peaked at $831K in Q3 2020.
  • 248 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on MetLife Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.